Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Clanet

Showing results (121-130 of 137) with videos related to

Pageof 14
Sort By:
World Journal of Urology|January 8, 2013
Impact of intermittent catheterization on the quality of life of multiple sclerosis patientsE Castel-Lacanal, X Gamé, X De Boissezon, et al.
Neurology|March 27, 2002
Absence of linkage to 8q24 in a European family with familial adult myoclonic epilepsy (FAME)P Labauge, L O Amer, M Simonetta-Moreau, et al.
Neurology|June 10, 2009
Multiple dural lesions mimicking meningiomas in patients with CCM3/PDCD10 mutationsP Labauge, B Fontaine, J-P Neau, et al.
Journal of Neurology|July 15, 2000
Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study GroupG Comi, L Kappos, M Clanet, et al.
Journal of Neuroimmunology|January 8, 2000
Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics GroupJ Reboul, C Mertens, F Levillayer, et al.
American Journal of Human Genetics|November 16, 2004
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformationsF Bergametti, C Denier, P Labauge, et al.
Neurology|September 25, 1998
A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics GroupC Mertens, D Brassat, J Reboul, et al.
Genes and Immunity|February 24, 2001
Chromosome 17q22-q24 and multiple sclerosis genetic susceptibility. American-French Multiple Sclerosis Genetic GroupB Fontaine, I Cournu, I Arnaud, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteriaG Edan, D Miller, M Clanet, et al.
Revue Neurologique|April 22, 2014
[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]C Lionnet, C Carra, X Ayrignac, et al.
Pageof 14

Showing results (121-130 of 137) with videos related to

Sort By:
Pageof 14
World Journal of Urology|January 8, 2013
Impact of intermittent catheterization on the quality of life of multiple sclerosis patientsE Castel-Lacanal, X Gamé, X De Boissezon, et al.
Neurology|March 27, 2002
Absence of linkage to 8q24 in a European family with familial adult myoclonic epilepsy (FAME)P Labauge, L O Amer, M Simonetta-Moreau, et al.
Neurology|June 10, 2009
Multiple dural lesions mimicking meningiomas in patients with CCM3/PDCD10 mutationsP Labauge, B Fontaine, J-P Neau, et al.
Journal of Neurology|July 15, 2000
Guidelines for autologous blood and marrow stem cell transplantation in multiple sclerosis: a consensus report written on behalf of the European Group for Blood and Marrow Transplantation and the European Charcot Foundation. BMT-MS Study GroupG Comi, L Kappos, M Clanet, et al.
Journal of Neuroimmunology|January 8, 2000
Cytokines in genetic susceptibility to multiple sclerosis: a candidate gene approach. French Multiple Sclerosis Genetics GroupJ Reboul, C Mertens, F Levillayer, et al.
American Journal of Human Genetics|November 16, 2004
Mutations within the programmed cell death 10 gene cause cerebral cavernous malformationsF Bergametti, C Denier, P Labauge, et al.
Neurology|September 25, 1998
A systematic study of oligodendrocyte growth factors as candidates for genetic susceptibility to MS. French Multiple Sclerosis Genetics GroupC Mertens, D Brassat, J Reboul, et al.
Genes and Immunity|February 24, 2001
Chromosome 17q22-q24 and multiple sclerosis genetic susceptibility. American-French Multiple Sclerosis Genetic GroupB Fontaine, I Cournu, I Arnaud, et al.
Journal of Neurology, Neurosurgery, and Psychiatry|February 1, 1997
Therapeutic effect of mitoxantrone combined with methylprednisolone in multiple sclerosis: a randomised multicentre study of active disease using MRI and clinical criteriaG Edan, D Miller, M Clanet, et al.
Revue Neurologique|April 22, 2014
[Cerebrotendinous xanthomatosis: a multicentric retrospective study of 15 adults, clinical and paraclinical typical and atypical aspects]C Lionnet, C Carra, X Ayrignac, et al.
Pageof 14